CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,003 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02487797
NCT02487797Phase 4Completed

A Randomized Double Blind Clinical Trial Comparing Oxytocin Low-dose and High-dose Regimens for Labor Augmentation

Northwestern University·interventional·Posted Jul 1, 2015·Updated Feb 11, 2022

In Brief

A Phase 4 clinical trial evaluating Oxytocin and Sodium Chloride 0.9% for Dystocia. Completed, enrolled 1,003 participants across 1 site.

Detailed Summary

Oxytocin is a medication that is often used to strengthen contractions to overcome delayed labor progress. The primary aim of this study is to determine whether receiving a higher dose of oxytocin lowers the chance of needing a cesarean section when compared to a lower dose of oxytocin. Other aims include examining the relationship between dose of oxytocin regimen and length of labor, postpartum hemorrhage, intrauterine infection, umbilical cord gas, neonatal Apgar score \<5 at 5 minutes, and need for neonatal intensive care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDystocia
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 1, 2015
Enrollment StartSep 28, 2015
Primary CompletionSep 1, 2020
Study CompletionSep 28, 2020
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 11.0 years ago

Interventions

Oxytocindrug

Sodium Chloride 0.9%other